Schwade N D, Chiou G C
Institute of Ocular Pharmacology, Texas A&M University College of Medicine, College Station, USA.
J Ocul Pharmacol Ther. 1995 Summer;11(2):125-34. doi: 10.1089/jop.1995.11.125.
A trabeculectomy model was used to test the efficacy of some Interleukin-1 blockers on the modulation of ophthalmic wound healing in the pigmented rabbit. The corticosteroid, methyl prednisolone, was used as a positive control and was effective in prolonging the time to failure of the trabeculectomy by 21%. The experimental compounds CK-17, CK-101A, CK-102 and CK-103A were more efficacious than vehicle control at prolonging the number of days before failure of the trabeculectomy by 55%, 55%, 30% and 79%, respectively. The CK- compounds increased the amount of time before failure of the fistula, with no side effects at the doses tested to date.
采用小梁切除术模型来测试一些白细胞介素 -1阻滞剂对色素兔眼伤口愈合调节的疗效。皮质类固醇甲泼尼龙用作阳性对照,可有效将小梁切除术失败时间延长21%。实验化合物CK -17、CK -101A、CK -102和CK -103A在延长小梁切除术失败前天数方面比赋形剂对照更有效,分别延长了55%、55%、30%和79%。CK类化合物增加了瘘管失败前的时间,在迄今为止测试的剂量下无副作用。